
Daniel P. Shook
Examiner (ID: 18974)
| Most Active Art Unit | 2898 |
| Art Unit(s) | 2823, 4116, 2896, 2898 |
| Total Applications | 1165 |
| Issued Applications | 1020 |
| Pending Applications | 77 |
| Abandoned Applications | 93 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19403605
[patent_doc_number] => 20240287116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH
[patent_app_type] => utility
[patent_app_number] => 18/570021
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570021
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/570021 | SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH | Jun 13, 2022 | Pending |
Array
(
[id] => 18285755
[patent_doc_number] => 20230101227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => COMPOSITIONS COMPRISING REVERSIBLY MODIFIED OLIGONUCLEOTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/836209
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35609
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836209
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/836209 | Compositions comprising reversibly modified oligonucleotides and uses thereof | Jun 8, 2022 | Issued |
Array
(
[id] => 18108009
[patent_doc_number] => 20230000889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => METHODS OF TREATING ACUTE MYELOID LEUKEMIA AND MANAGING CYTOPENIA
[patent_app_type] => utility
[patent_app_number] => 17/834642
[patent_app_country] => US
[patent_app_date] => 2022-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17834642
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/834642 | METHODS OF TREATING ACUTE MYELOID LEUKEMIA AND MANAGING CYTOPENIA | Jun 6, 2022 | Abandoned |
Array
(
[id] => 18101202
[patent_doc_number] => 11541071
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-01-03
[patent_title] => Nucleoside derivatives and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/664304
[patent_app_country] => US
[patent_app_date] => 2022-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38213
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17664304
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/664304 | Nucleoside derivatives and methods of use thereof | May 19, 2022 | Issued |
Array
(
[id] => 19331288
[patent_doc_number] => 20240245718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => MEDIUM MOLECULAR WEIGHT HEPARIN FOR USE IN THE TREATMENT OF ENDOTHELIOPATHY
[patent_app_type] => utility
[patent_app_number] => 18/290533
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18290533
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/290533 | MEDIUM MOLECULAR WEIGHT HEPARIN FOR USE IN THE TREATMENT OF ENDOTHELIOPATHY | May 15, 2022 | Pending |
Array
(
[id] => 18647796
[patent_doc_number] => 20230293569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => MODULATING NUDIX HOMOLOGY DOMAIN (NHD) WITH NICOTINAMIDE MONONUCLEOTIDE ANALOGS AND DERIVATIVES OF SAME
[patent_app_type] => utility
[patent_app_number] => 17/737541
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737541
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/737541 | Modulating Nudix homology domain (NHD) with nicotinamide mononucleotide analogs and derivatives of same | May 4, 2022 | Issued |
Array
(
[id] => 19165811
[patent_doc_number] => 11981698
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => Methods of preparing reduced nicotinamide riboside and derivatives thereof
[patent_app_type] => utility
[patent_app_number] => 17/736834
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8002
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736834
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736834 | Methods of preparing reduced nicotinamide riboside and derivatives thereof | May 3, 2022 | Issued |
Array
(
[id] => 17911324
[patent_doc_number] => 20220313719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => METHODS OF TREATING DISEASES ASSOCIATED WITH CHANGES IN PLATELET COUNTS USING PROTEIN KINASE A ACTIVATOR AND INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/728895
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8682
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17728895
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/728895 | METHODS OF TREATING DISEASES ASSOCIATED WITH CHANGES IN PLATELET COUNTS USING PROTEIN KINASE A ACTIVATOR AND INHIBITOR | Apr 24, 2022 | Abandoned |
Array
(
[id] => 18245953
[patent_doc_number] => 11602516
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-03-14
[patent_title] => Treating benign prostatic hyperplasia
[patent_app_type] => utility
[patent_app_number] => 17/727675
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 21885
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17727675
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/727675 | Treating benign prostatic hyperplasia | Apr 21, 2022 | Issued |
Array
(
[id] => 19246778
[patent_doc_number] => 20240197762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => NUTRITIONAL COMPOSITION FOR STIMULATIONG BIFIDOBACTERIA
[patent_app_type] => utility
[patent_app_number] => 18/286505
[patent_app_country] => US
[patent_app_date] => 2022-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18286505
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/286505 | NUTRITIONAL COMPOSITION FOR STIMULATIONG BIFIDOBACTERIA | Apr 11, 2022 | Pending |
Array
(
[id] => 19889077
[patent_doc_number] => 20250114389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-10
[patent_title] => NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/285778
[patent_app_country] => US
[patent_app_date] => 2022-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18285778
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/285778 | NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS | Apr 10, 2022 | Pending |
Array
(
[id] => 19586383
[patent_doc_number] => 20240383940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => SYNTHESIS OF TRINUCLEOTIDE AND TETRANUCLEOTIDE CAPS FOR MRNA PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/284395
[patent_app_country] => US
[patent_app_date] => 2022-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21676
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -66
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18284395
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/284395 | SYNTHESIS OF TRINUCLEOTIDE AND TETRANUCLEOTIDE CAPS FOR MRNA PRODUCTION | Mar 29, 2022 | Pending |
Array
(
[id] => 19265319
[patent_doc_number] => 20240209018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => UNIVERSAL LINKER REAGENTS FOR DNA SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 18/551834
[patent_app_country] => US
[patent_app_date] => 2022-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11365
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551834
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551834 | UNIVERSAL LINKER REAGENTS FOR DNA SYNTHESIS | Mar 21, 2022 | Pending |
Array
(
[id] => 18994591
[patent_doc_number] => 11911408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Synergistic formulations of adenosine receptor modulating agents and anticholinergics
[patent_app_type] => utility
[patent_app_number] => 17/692383
[patent_app_country] => US
[patent_app_date] => 2022-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13256
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692383
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/692383 | Synergistic formulations of adenosine receptor modulating agents and anticholinergics | Mar 10, 2022 | Issued |
Array
(
[id] => 18930973
[patent_doc_number] => 11883367
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => 6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/690587
[patent_app_country] => US
[patent_app_date] => 2022-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69496
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 664
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17690587
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/690587 | 6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors | Mar 8, 2022 | Issued |
Array
(
[id] => 19139649
[patent_doc_number] => 20240138410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => AGRICULTURAL COMPOSITION COMPRISING KASUGAMYCIN
[patent_app_type] => utility
[patent_app_number] => 18/548110
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548110
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548110 | AGRICULTURAL COMPOSITION COMPRISING KASUGAMYCIN | Feb 27, 2022 | Pending |
Array
(
[id] => 17837714
[patent_doc_number] => 20220275019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => HYDROCINNAMOYL PROTECTED RIBOGUANOSINE PHOSPHORAMIDITES FOR DECREASING DEPYRIMIDINATION FROM ALKYL AMINE EXPOSURE DURING FINAL DEPROTECTION
[patent_app_type] => utility
[patent_app_number] => 17/681731
[patent_app_country] => US
[patent_app_date] => 2022-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681731
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/681731 | HYDROCINNAMOYL PROTECTED RIBOGUANOSINE PHOSPHORAMIDITES FOR DECREASING DEPYRIMIDINATION FROM ALKYL AMINE EXPOSURE DURING FINAL DEPROTECTION | Feb 25, 2022 | Pending |
Array
(
[id] => 18871146
[patent_doc_number] => 11858931
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Amino acid compounds with unbranched linkers and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/679002
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 2
[patent_no_of_words] => 32445
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17679002
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/679002 | Amino acid compounds with unbranched linkers and methods of use | Feb 22, 2022 | Issued |
Array
(
[id] => 19280105
[patent_doc_number] => 20240216578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => COMPOSITE ULTRATHIN COATING FILM WITH INHIBITORY ACTIVITY AGAINST HYPERINFLAMMATORY RESPONSE AND BACTERIA, IMPLANT INCLUDING SAME, AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 18/569988
[patent_app_country] => US
[patent_app_date] => 2022-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5362
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18569988
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/569988 | Composite ultrathin coating film with inhibitory activity against hyperinflammatory response and bacteria, implant including same, and preparation method therefor | Feb 13, 2022 | Issued |
Array
(
[id] => 20343127
[patent_doc_number] => 12466849
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-11
[patent_title] => Anti-viral and anti-tumoral compounds
[patent_app_type] => utility
[patent_app_number] => 17/583378
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 76
[patent_figures_cnt] => 105
[patent_no_of_words] => 65301
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17583378
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/583378 | Anti-viral and anti-tumoral compounds | Jan 24, 2022 | Issued |